Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Vargas

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studiesA J Sanyal, T D Boyer, R T Frederick, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 11, 1998
The influence of hepatitis C virus genotypes on the outcome of liver transplantationH E Vargas, T Laskus, L F Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized studyG B Klintmalm, S Feng, J R Lake, et al.
Transplantation|October 6, 1997
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipientsH E Vargas, T Laskus, M Radkowski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2018
Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter studyD M Chascsa, O Y Mousa, S Pungpapong, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studiesA J Sanyal, T D Boyer, R T Frederick, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 11, 1998
The influence of hepatitis C virus genotypes on the outcome of liver transplantationH E Vargas, T Laskus, L F Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized studyG B Klintmalm, S Feng, J R Lake, et al.
Transplantation|October 6, 1997
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipientsH E Vargas, T Laskus, M Radkowski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2018
Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter studyD M Chascsa, O Y Mousa, S Pungpapong, et al.
Pageof 2